Human Gene Therapy

Papers
(The H4-Index of Human Gene Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation115
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid92
AVLAYAH and KRESLADI Win FDA Accelerated Approvals80
Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell Disease65
PASTE, Don't Cut: Genome Editing Tool Looks Beyond CRISPR and Prime56
Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future55
Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies47
Intra-Articular Delivery of an AAV-Anti-TNF-α Vector Alleviates the Progress of Arthritis in a RA Mouse Model45
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II42
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases40
SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential36
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian Hamsters34
SNAC: A Single-Nuclei Atlas of Capsid Distribution in Nonhuman Primate Eye34
Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis34
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study34
Adeno-Associated Virus-Mediated Interleukin-12 Gene Expression Alleviates Lung Inflammation and Type 2 T-Helper-Responses in Ovalbumin-Sensitized Asthmatic Mice33
Meta-Analysis and Optimization of the In Vitro Immortalization Assay for Safety Assessment of Retroviral Vectors in Gene Therapy31
Abstracts31
Characterizing Complex Populations of Endogenous Adeno-Associated Viruses by Single-Genome Amplification30
uniQure Gene Therapy Significantly Slows Huntington Disease Progression30
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell30
Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis30
Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop29
Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases28
Advancing Precision Medicine with Gene and Cell Therapy in Malaysia: Ethical, Legal, and Social Implications28
Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders27
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature26
0.26670002937317